EUROPEAN SEMESTER: AN OPPORTUNITY FOR THE EU GENERIC AND BIOSIMILAR MEDICINES INDUSTRIES
Brussels, 10 December 2013 - The EGA welcomes today’s adoption of the Council’s conclusion “Reflection process on modern, responsive and sustainable health systems”. The following recommendations to the European institutions are a crucial step forward in recognising investment in health as paramount for market sustainability in a competitive Europe:
16th IGPA CONFERENCE: A GLOBAL MARKET – A GLOBAL INDUSTRY
Brussels, 10 December 2013 - Today, the International Generic Pharmaceutical Alliance (IGPA) hosted its 16th Annual Conference “A Global Market - A Global Industry”. This event brought together more than 200 representatives from the pharmaceutical industry worldwide, European institutions, national authorities, and high level representatives from the IGPA. Addressing the audience, Laurette Onkelinx, Belgian Deputy Prime Minister and Minister of Social Affairs and Public Health, stressed the invaluable contribution of generic medicines to society stating that the generic medicines sector is a “sustainable industry that can invest in quality”.
THE EGA FULLY SUPPORTS THE WORLD AIDS DAY
The EGA fully supports the World AIDS Day and strives with its members to provide greater access to pro-competitive and high quality treatments to HIV/AIDS patients. The EGA praises the initiatives taken by members active in the fight against the virus and to projects that improve the life of HIV/AIDS patients. Thanks to the access and savings generated by the generic medicines industry, the innovation circle is significantly stimulated.
The EGA welcomes the publication of the Guiding Principles Promoting Good Governance in the Pharmaceutical Sector
22 January 2014
23 - 24 January 2014
18 - 19 March 2014
03 - 04 April 2014
12th EGA International Biosimilar Medicines Conference
coordinated by the European Biosimilars Group, a Sector Group of the EGA More details available at h...
KPMG Report - Advice on the implementation of EU-Directive 2011/62/EU
Advice on the implementation of EU-Directive 2011/62/EU
KPMG Report Download PDF
Folder Web Dowload PDF
EGA Biosimilars Handbook
EGA Q&A on the revised EMA Bioequivalence Guideline
EGA Q&A on the revised EMA Bioequivalence Guideline, the EGA Contribution to the Promotion of Harmonised EU interpretation of the revised Bioequivalence Requirement
EGA Vision 2015, the Way forward for more Efficient Regulatory Environment for Generic and Biosimilar Medicines